{
  "scenario_id": "biotechnology_ip_protection_strategy_2025",
  "context": "Biotechnology company developing novel gene therapy platform needs comprehensive IP protection strategy across multiple jurisdictions",
  "stakeholders": {
    "requester": "Chief Scientific Officer",
    "approvers": [
      "CEO",
      "Chief Legal Officer",
      "Board of Directors"
    ],
    "influencers": [
      "VP Research",
      "Head of Business Development",
      "External IP Counsel",
      "Regulatory Affairs Lead"
    ]
  },
  "request": {
    "amount": "$12,000,000",
    "purpose": "Multi-year IP protection strategy including patent filings, licensing agreements, and defensive publications",
    "urgency": "high",
    "justification": "Gene therapy platform represents $2B market opportunity; strong IP position critical for partnerships and market leadership"
  },
  "decision_process": [
    {
      "stage": "ip_landscape_analysis",
      "duration": "8 weeks",
      "activities": [
        "Patent landscape review",
        "Freedom-to-operate analysis",
        "Competitive IP assessment",
        "Licensing opportunity evaluation"
      ],
      "outcome": "Identified 15 core patent families and 8 licensing opportunities"
    },
    {
      "stage": "strategic_positioning",
      "duration": "6 weeks",
      "activities": [
        "IP portfolio valuation",
        "Market positioning analysis",
        "Defensive publication strategy",
        "Licensing revenue modeling"
      ],
      "outcome": "Developed comprehensive IP strategy balancing protection with commercialization"
    },
    {
      "stage": "regulatory_considerations",
      "duration": "4 weeks",
      "activities": [
        "Patent eligibility assessment",
        "Regulatory exclusivity analysis",
        "International filing strategy",
        "IP enforcement planning"
      ],
      "outcome": "Clear pathway for patent protection in key markets (US, EU, China, Japan)"
    },
    {
      "stage": "financial_evaluation",
      "duration": "4 weeks",
      "activities": [
        "Cost-benefit analysis",
        "ROI projections",
        "Funding requirements",
        "Risk assessment"
      ],
      "outcome": "Projected 300% ROI over 10 years with strong defensive positioning"
    },
    {
      "stage": "executive_approval",
      "duration": "2 weeks",
      "activities": [
        "Board presentation",
        "Q&A session",
        "Final strategy approval",
        "Budget allocation"
      ],
      "outcome": "Approved comprehensive IP protection strategy with phased implementation"
    }
  ],
  "business_impact": {
    "expected_outcome": "Secure IP leadership in gene therapy space enabling premium partnerships and market dominance",
    "projected_value": "$800,000,000",
    "risk_factors": [
      "Patent rejections in key jurisdictions",
      "Competitor workarounds",
      "Regulatory changes affecting patent eligibility",
      "High litigation costs"
    ]
  },
  "decision_criteria": [
    "IP strength and defensibility",
    "Market protection coverage",
    "Financial returns",
    "Regulatory compliance",
    "Implementation feasibility"
  ],
  "outcome": "Approved",
  "lessons_learned": "Early defensive publications prevented competitor blocking patents; international filing strategy critical for global protection"
}